Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016
Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment? Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Retrospective cohort study of adult cystic fibrosis patients colonised with achromobacter Xylosoxidans Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Interim data from a long-term safety, tolerability, and efficacy study of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonas aeruginosa infection Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014
LATE-BREAKING ABSTRACT: Pseudomonas aeruginosa strain prevalence, adaptation and diversification, during chronic lung infections of UK non-cystic fibrosis bronchiectasis patients Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016
Susceptibility of problem respiratory pathogens to levofloxacin in cystic fibrosis (CF) Source: Eur Respir J 2002; 20: Suppl. 38, 526s Year: 2002
Alternating inhaled antibiotic therapy in CF: A single center analysis Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015
Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010
Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
A randomised comparison of two tobramycin formulations in cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) infection for pharmacokinetic and therapeutic equivalence Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013
The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Persistence of candida dubliniensis in the lower airways of cystic fibrosis patients Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Viral infections trigger exacerbations of cystic fibrosis in adults and children Source: Eur Respir J 2012; 40: 510-512 Year: 2012
Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa : Role of inhaled colistin Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Does the cystic fibrosis phlegm feed the pseudomonas? Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
Rhinovirus infections in the upper and lower airways of young Australian children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014